Sentences with phrase «cash per share outstanding»

Not exact matches

Under the terms of the agreement, a subsidiary of HPE will commence a tender offer to purchase any and all of the outstanding shares of Nimble common stock for $ 12.50 per share in cash.

That bid ultimately failed, although it did force General Dynamics to amend its offer to acquire all outstanding shares of CSRA for $ 41.25 per share in cash, an increase from the original $ 40.75 per share offer.

Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.

These two sites only give cash flow only but we can get cash flow per share by (cash flow — preferred dividends / average outstanding shares)

In preference to the holders of our common stock, each share of preferred stock is entitled to receive, on a pari passu basis, cash dividends at the rate of 6 % of the original issue price per annum on each outstanding share of preferred stock.

JERUSALEM --(BUSINESS WIRE)-- Apr. 21, 2015 — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $ 82.00 per Mylan share, with the consideration to be comprised of approximately 50 percent cash and 50 percent stock.

2017.08.23 Royal Bank of Canada to redeem Non-Cumulative First Preferred Shares Series AB and Non-Cumulative Perpetual First Preferred Shares Series C - 1 Royal Bank of Canada (RY on TSX and NYSE) today announced its intention, subject to the approval of the Office of the Superintendent of Financial Institutions (OSFI), to redeem all of its issued and outstanding Non-Cumulative First Preferred Shares Series AB (the â $ Series AB sharesâ $) on September 27, 2017, for cash at a redemption price of CDN $ 25.00 per share, together with all declared and unpaid dividends.

In the event of a change of control (as defined in the plan), the compensation committee may, in its discretion, provide for any or all of the following actions: (i) awards may be continued, assumed, or substituted with new rights, (ii) awards may be purchased for cash equal to the excess (if any) of the highest price per share of common stock paid in the change in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerated.

Royal Bank of Canada (RY on TSX and NYSE) today announced its intention, subject to the approval of the Office of the Superintendent of Financial Institutions (OSFI), to redeem all of its issued and outstanding Non-Cumulative First Preferred Shares Series AB (the â $ Series AB sharesâ $) on September 27, 2017, for cash at a redemption price of CDN $ 25.00 per share, together with all declared and unpaid dividends.

terminate either (a) each outstanding option or (b) each outstanding option that is fully exercisable as of the date of such transaction, in exchange for a cash payment equal in amount to the excess, if any, of the fair market value, as determined by our board of directors, of a share of our common stock over the per - share exercise price of each such option, multiplied by the number of shares subject to each such option.

BOSTON (March 12, 2018)-- MFS Investment Grade Municipal Trust (the «fund»)(NYSE: CXH) announced today that it will conduct a cash tender offer to purchase up to 7.5 percent of the fund's outstanding common shares (the «shares») at a price per share equal to 98 percent of the fund's net asset value (NAV) per share as of the close of regular trading on the New York Stock Exchange (NYSE) on the date the tender offer expires.

-LCB--LSB-(Sum of Discounted Future Enterprise Free Cash Flows — Total Debt — Preferred Stock + Total Cash) / Shares Outstanding] / Next Fiscal Year's Earnings Per Share -RCB-

BVF Acquisition LLC (the «Purchaser»), a wholly owned subsidiary of Biotechnology Value Fund, L.P. («BVF»), announced today that it has commenced a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (NasdaqGM: AVGN)(«Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions described below.

Additionally, on January 23, 2009, we commenced a cash tender offer to purchase any and all of the outstanding Shares that we do not own at a price of $ 1.00 per Share (the «Offer»).

Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company, today confirmed that BVF Acquisition LLC, a wholly owned subsidiary of Biotechnology Value Fund, L.P. (collectively, «BVF»), had commenced an unsolicited tender offer to purchase all of the outstanding shares of Avigen's common stock that BVF does not already own for $ 1.00 per share in cash.

Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $ 1.00 Per Share Tender Offer provides stockholders with a near - term cash alternative if BVF nominees are elected BVF reaffirms support for downside - protected merger with MediciNova NEW YORK, Jan. 15 / PRNewswire / — Biotechnology Value Fund, L.P. («BVF») announced today that it intends to make a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions descrOutstanding Shares Of Avigen At $ 1.00 Per Share Tender Offer provides stockholders with a near - term cash alternative if BVF nominees are elected BVF reaffirms support for downside - protected merger with MediciNova NEW YORK, Jan. 15 / PRNewswire / — Biotechnology Value Fund, L.P. («BVF») announced today that it intends to make a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions described belPer Share Tender Offer provides stockholders with a near - term cash alternative if BVF nominees are elected BVF reaffirms support for downside - protected merger with MediciNova NEW YORK, Jan. 15 / PRNewswire / — Biotechnology Value Fund, L.P. («BVF») announced today that it intends to make a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions described bShare Tender Offer provides stockholders with a near - term cash alternative if BVF nominees are elected BVF reaffirms support for downside - protected merger with MediciNova NEW YORK, Jan. 15 / PRNewswire / — Biotechnology Value Fund, L.P. («BVF») announced today that it intends to make a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions descroutstanding common stock of Avigen, Inc. (Nasdaq: AVGN — News; «Avigen») that BVF does not own at a price of $ 1.00 per share under the conditions described belper share under the conditions described bshare under the conditions described below.

Cash flow per share was unchanged at $ 0.17 on more shares outstanding.

Tiberius Capital launched its tender offer for MATH on June 1 this year at $ 1.15 cash per share, bidding for 51 % of the outstanding shares.

Tiberius Capital launched its original tender offer for MATH on June 1, 2009 at $ 1.15 cash per share, bidding for 51 % of the outstanding shares.

Add back the $ 11 mm cash balance on June 30, 2009 and the company is sitting on nearly $ 6.4 in cash per share (based on 7.5 mm outstanding).

Moreover, given that the top five (by percentage ownership per Securities and Exchange Commission public filings) Facet owners appear to represent over 45 % of the outstanding shares, the Alternate Slate believes that the Company's management and Incumbent Board may, with only modest effort, conclude that the majority of Facet investors agree with the cash dividend and sale platform endorsed by the Alternate Slate.

BVF Acquisition LLC (the «Purchaser»), an affiliate of Biotechnology Value Fund L.P. («BVF»), which has commenced a cash tender offer to purchase all of the outstanding shares of Avigen, Inc. (Nasdaq: AVGN)(«Avigen») for $ 1.00 per share, announced today that it has extended the expiration date for the tender offer to 6:00 p.m., New York City time, on Friday, March 6, 2009.

Such cash would equate to future post-merger liquidating distribution of $ 13.26 per share assuming the full exercise of the rights in the rights offering resulting in a total of 3,706,700 units outstanding.

-- Initiate a tender offer to retire (at least) 1/3 of Argo's outstanding shares, priced at 17.6 p (a 15 % discount to current net cash / investments per share).

Each share of Class A Common Stock issued and outstanding immediately prior to the Effective Date was converted, as of the Effective Date, into the right to receive $ 3.075 per share, less any required withholding taxes, plus a contingent right to receive an additional pro rata cash amount if RISCORP recovers any amounts in connection with the litigation currently pending against Zenith Insurance Company and Arthur Andersen LLP.

I am sending you this letter to make sure that you are aware that Tiberius is offering to purchase all outstanding shares of common stock of MathStar, Inc., a Delaware corporation, («MathStar» or the «Company»), par value $ 0.01 per share (the «Shares»), at a net price per share equal to $ 1.25 in cash (without interest and subject to applicable withholding taxes), upon the terms and subject to the conditions set forth in the Offer to Purchase (the «Offer to Purchase») and the related Letter of Transmittal (the «Letter of Transmittal» and, together with the Offer to Purchase and any amendments or supplements thereto, the «Offer&rashares of common stock of MathStar, Inc., a Delaware corporation, («MathStar» or the «Company»), par value $ 0.01 per share (the «Shares»), at a net price per share equal to $ 1.25 in cash (without interest and subject to applicable withholding taxes), upon the terms and subject to the conditions set forth in the Offer to Purchase (the «Offer to Purchase») and the related Letter of Transmittal (the «Letter of Transmittal» and, together with the Offer to Purchase and any amendments or supplements thereto, the «Offer&raShares»), at a net price per share equal to $ 1.25 in cash (without interest and subject to applicable withholding taxes), upon the terms and subject to the conditions set forth in the Offer to Purchase (the «Offer to Purchase») and the related Letter of Transmittal (the «Letter of Transmittal» and, together with the Offer to Purchase and any amendments or supplements thereto, the «Offer»).

NEW YORK, March 6, 2009 — BVF Acquisition LLC (the «Purchaser»), an affiliate of Biotechnology Value Fund L.P. («BVF»), which has commenced a cash tender offer to purchase all of the outstanding shares of Avigen, Inc. (Nasdaq: AVGN)(«Avigen») for $ 1.00 per share, announced today that it has extended the expiration date for the tender offer to 6:00 p.m., New York City time, on Friday, April 3, 2009.

The price of one share of the mutual fund (usually called Net Asset Value (NAV) per share) is usually calculated at the close of business, and is, as the name implies, the net worth of all the shares in companies that the fund owns plus cash on hand etc divided by the number of mutual fund shares outstanding.

Net Current Asset Value (NCAV) = cash and short - term investments + (0.75 * accounts receivable) + (0.5 * inventory)-- total liabilities — preferred stock The resulting value can then be divided by the number of common shares outstanding to find the NCAV per share.

This drops their cash & guaranteed receivables to $ 76.8 mio — with an expected 21.5 mio ADRs outstanding, that equates to $ 3.57 cash per share.

AUSTIN, Texas, April 20, 2009 — Trilogy Enterprises, Inc. («Trilogy»), a provider of technology powered business services to the automotive industry, today announced that its wholly - owned subsidiary, Infield Acquisition, Inc., has commenced a tender offer to acquire all of the outstanding shares of common stock of Autobytel Inc. (Nasdaq: ABTL) for $ 0.35 net per share in cash.

Starwood Hotels & Resorts Worldwide, Inc. (NYSE: HOT)(«Starwood») today announced that the consortium consisting of Anbang Insurance Group Co., Ltd., J.C. Flowers & Co. and Primavera Capital Limited (the «Consortium») has informed Starwood that, as a result of market considerations, it has withdrawn its non-binding proposal to acquire all of the outstanding shares of common stock of Starwood for $ 82.75 per share in cash and does not intend to make another proposal.

So, to further demonstrate our seriousness and encourage you to move forward now, I am writing to increase EA's offer to acquire all of the outstanding shares of Take - Two to $ 26 per share in cash.

On February 8, 2018, the Company's Board of Directors established a record date of March 30, 2018 and a payment date of May 9, 2018 for a cash dividend of $ 0.34 per share of the Company's outstanding common stock.

Bayer has made an all - cash offer to acquire all of the issued and outstanding shares of common stock of Monsanto Company for $ 122 per share or an aggregate value of $ 62 billion.

L.P. (together with affiliates, «KKR») announced that they have signed an investor agreement under which KKR will launch a voluntary public tender offer for all outstanding publicly - traded shares of GfK for EUR 43.50 per share in an all - cash transaction.

BHP Billiton and Petrohawk Energy Corporation («Petrohawk») announced late yesterday that the companies have entered into a definitive agreement for BHP Billiton to acquire Petrohawk for $ 38.75 per share by means of an all - cash tender offer for all of the issued and outstanding shares of Petrohawk, representing a total equity value of approximately $ 12.1 billion and a total enterprise value of approximately $ 15.1 billion, including the assumption of net debt (more...)

Under the terms of the agreement, General Dynamics will commence a cash tender offer to purchase outstanding shares of CSRA common stock for $ 40.75 per share.

Bloomberg will acquire all 25,116,830 outstanding shares of BNA for $ 39.50 per share in cash for a total purchase price of approximately $ 990 million.

Analysts and other industry experts are surprised and confounded by Brookfield's all - cash offer of $ 17 per share for Rouse's outstanding shares.

The agreement also provides that a Brookfield subsidiary will commence a tender offer to purchase all of MPG's outstanding preferred shares for $ 25.00 per share in cash, without interest.

Health Care REIT Inc. entered into a definitive agreement to acquire all of the outstanding common stock of Sunrise Senior Living Inc. for $ 14.50 per share in an all cash transaction, or $ 845 million.

Brookfield Residential Properties Inc. (the «Company» or «Brookfield Residential»)(BRP: NYSE / TSX) announced today that it has received shareholder approval for the going private transaction pursuant to which 1927726 Ontario Inc., a wholly owned subsidiary of Brookfield Asset Management Inc., will acquire all of the issued and outstanding common shares of Brookfield Residential that Brookfield Asset Management Inc. and its affiliates do not already own for cash consideration of US$ 24.25 per Common Share by way of a plan of arrangement (the «Arrangement»).